Among the 16 established inhibitors from various studies that inhibit VEGF activity, Cediranib (Batchelor et al., 2007b), CEP-7055 (Jones-Bolin et al., 2006b) found to be best best known for the treatment of glioblastoma. This evidence concerns the gene VEGFA and glioblastoma.